The biochemical pathways of central nervous system neural degeneration in niacin deficiency

Neural Regeneration Research

Volumn 9, Issue 16, 2014, Pages 1509-1513

  Fu, Lin Shan ^a   Doreswamy, Venkatesh ^b   Prakash, Ravi ^b  

^a First Peoples Hospital of Yancheng   (China)

^b M S RAMAIAH MEDICAL COLLEGE   (India)

Author keywords

BDNF TRKB pathway; Biochemical pathways of degeneration; Chromatolysis; Kyneurenic acid; Neural degeneration; Niacin deficiency

Indexed keywords

ADENOSINE TRIPHOSPHATE; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDOLEAMINE 2, 3 DIOXYGENASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINIC ACID; QUINOLINIC ACID; REACTIVE OXYGEN METABOLITE; TRYPTOPHAN 2, 3 DIOXYGENASE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; AXONAL INJURY; CELL DEATH; CENTRAL NERVOUS SYSTEM; DNA DAMAGE; DNA REPAIR; GENE OVEREXPRESSION; GENETIC TRAIT; HUMAN; LIPID PEROXIDATION; MOTOR CORTEX; NERVE CELL LESION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVE FIBER GROWTH; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NICOTINIC ACID DEFICIENCY; NONHUMAN; OXIDATIVE STRESS; PELLAGRA; RESPIRATORY FAILURE; TRYPTOPHAN METABOLISM; WALLERIAN DEGENERATION;

EID: 84907152440     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.4103/1673-5374.139475     Document Type: Article

References (66)

1. Abdallah DM (2010) Nicotinamide alleviates indomethacin induced gastric ulcers: a novel antiulcer agent. Eur J Pharmacol 627:276-280.
2. Aikawa H, Suzuki K (1986) Lesions in the skin, intestine, and central nervous system induced by an antimetabolite of niacin. Am J Pathol 122:335-342.
3. Ali YO, Ruan K, Zhai RG (2011) NMNAT suppresses Tau-induced neurodegeneration by promoting clearance of hyperphosphorylated Tau oligomers in a Drosophila model of tauopathy. Hum Mol Genet 21:237-250.
4. Anne M. Fagan, Guojun Bu, Yuling Sun, Alan Daughertyi, David M. Holtzman (1996) Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J Biol Chem 271:30121-30125.
5. Ayoub IA, Lee EJ, Ogilvy C, Flint BM, Maynard KI (1999) Nicotinamide reduces infarction up to two hours after the onset of permanent focal cerebral ischemia in wistar rats. Neurosci Lett 259:21-24.
6. Berger F, Lau C, Dahlmann M, Ziegler M (2005) Subcellular compartmentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J Biol Chem 280:36334-36341.
7. Berger NA. Poly (ADP-ribose) in the cellular response to DNA damage. Radiat Res 101:4-15.
8. Bibel M, Barde YA (2000) Neurotrophins: Key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 14:2919-2937.
9. Boulu RG, Mesenge C, Charriaut-Marlangue C, Verrecchia C, Plotkine M (2001) Neuronal death: potential role of the nuclear enzyme, poly (ADP-ribose) polymerase. Bull Acad Natl Med 185: 555-563.
10. Braidy N, Guillemin G, Grant R (2008) Promotion of cellular NAD Anabolism: therapeutic potential for oxidative stress in ageing and Alzheimer’s disease. Neurotox Res 13:1-12.
11. Brune B, Dimmeler S, Molina Y, Vedia L, Lapetina EG (1994) Nitric oxide: a signal for ADP-ribosylation of proteins. Life Sci 54:61-70.
12. Burkle A (2005) Poly(ADP-ribose). The most elaborate metabolite of NAD+. FEBS J 272:4576-4589.
13. Chambon P, Weill JD, Mandel P (1963) Nicotinamide mononucleotide activation of a new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. Biochem Biophys Res Commun 11:39-43.
14. Cipriani G, Rapizzi E, Vannacci A, Rizzuto R, Moroni F, Chiarugi A (2005) Nuclear poly(ADP-ribose) polymerase-1 rapidly triggers mitochondrial dysfunction. J Biol Chem 280:17227-17234.
15. Coleman MP, Freeman MR (2010) Wallerian degeneration, wld(s), and nmnat. Annu Rev Neurosci 33:245-267.
16. Conforti L, Janeckova L, Wagner D, Mazzola F, Cialabrini L, Di Stefano M, Orsomando G, Magni G, Bendotti C, Smyth N, Coleman M (2011) Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration. FEBS J 278:2666-2679.
17. Cosi C, Marien M (1998) Decreases in mouse brain NAD+ and ATP induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): prevention by the poly(ADP-ribose) polymerase inhibitor, benzamide. Brain Res 809:58-67.
18. Cui X, Chopp M, Zacharek A, Roberts C, Buller B, Ion M, Chen J (2010) Niacin treatment of stroke increases synaptic plasticity and axon growth in rats. Stroke 41:2044-2049.
19. Davies NW, Guillemin G, Brew BJ (2010) Tryptophan, neurodegeneration and HIV-associated neurocognitive disorder. Int J Tryptophan Res 3:121-140.
20. Di Lisa F, Ziegler M (2001) Pathophysiological relevance of mitochondria in NAD(+) metabolism. FEBS Lett 492:4-8.
21. Dimmeler S, Brune B (1992) Characterization of a nitric-oxidecatalysed ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase. Eur J Biochem 210:305-310.
22. Du L, Zhang X, Han YY, Burke NA, Kochanek PM, Watkins SC, Graham SH, Carcillo JA, Szabo C, Clark RS (2003) J Intra-mitochondrial poly(ADP-ribosylation) contributes to NAD+ depletion and cell death induced by oxidative stress. Biol Chem 278:18426-18433.
23. Elam MB, Hunninghake DB, Davis KB, Garg R, Johnson C, Egan D, Kostis JB, Sheps DS, Brinton EA (2000) Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: The admit study: A randomized trial. Arterial disease multiple intervention trial. JAMA 284:1263-1270.
24. Endo T, Spenger C, Tominaga T, Brene S, Olson L (2007) Cortical sensory map rearrangement after spinal cord injury: Fmri responses linked to nogo signalling. Brain 130:2951-296.
25. Feng Y, Yan T, Zheng J, Ge X, Mu Y, Zhang Y, Wu D, Du JL, Zhai Q (2010) Overexpression of Wld(S) or Nmnat2 in mauthner cells by single-cell electroporation delays axon degeneration in live zebrafish. J Neurosci Res 88:3319-3327.
26. Gilley J, Coleman MP (2010) Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol 8:e1000300.
27. Gordon T (2009) The role of neurotrophic factors in nerve regeneration. Neurosurg Focus 26:E3.
28. Hageman GJ, Stierum RH, van Herwijnen MH, van der Veer MS, Kleinjans JC (1998) Nicotinic acid supplementation: effects on niacin status, cytogenetic damage, and poly(ADP-ribosylation) in lymphocytes of smokers. Nutr Cancer 32:113-120.
29. Hendricks WM (1991) Pellagra and pellagralike dermatoses: etiology, differential diagnosis, dermatopathology, and treatment. Semin Dermatol 10:282-292.
30. Jacobson EL, Shieh WH, Huang AC (1999) Mapping the role of NAD metabolism in prevention and treatment of carcinogenesis. Mol Cell Biochem 193:69-74.
31. Josephson A, Trifunovski A, Scheele C, Widenfalk J, Wahlestedt C, Brene S, Olson L, Spenger C (2003) Activity-induced and developmental downregulation of the nogo receptor. Cell Tissue Res 311:333-342.
32. Kamat JP, Devasagayam TP (1996) Methylene blue plus light-induced lipid peroxidation in rat liver microsomes: inhibition by nicotinamide (vitamin B3) and other antioxidants. Chem Biol Interact 99:1-16.
33. Klaidman L, Morales M, Kem S, Yang J, Chang ML, Adams JD Jr (2003) Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function. Pharmacology 69:150-157.
34. Klaidman LK, Mukherjee SK, Adams JD (2001) Oxidative changes in brain pyridine nucleotides and neuroprotection using nicotinamide. Biochim Biophys Acta 1525:136-148.
35. Langworthy OR (1931) Lesions of the central nervous system characteristic of pellagra. Brain 54:291-302.
36. Li F, Li L, Song XY, Zhong JH, Luo XG, Xian CJ, Zhou XF (2009) Preconditioning selective ventral root injury promotes plasticity of ascending sensory neurons in the injured spinal cord of adult rats-possible roles of brain-derived neurotrophic factor, trkb and p75 neurotrophin receptor. Eur J Neurosci 30:1280-1296.
37. Lo EH, Bosque-Hamilton P, Meng W (1998) Inhibition of poly(ADP-ribose) polymerase: reduction of ischemic injury and attenuation of N-methyl-D-aspartate-induced neurotransmitter dysregulation. Stroke 29:830-836.
38. Maiese K, Chong ZZ (2003) Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. Trends Pharmacol Sci 24:228-232.
39. Mandir AS, Przedborski S, Jackson-Lewis V, Wang ZQ, Simbulan-Rosenthal CM, Smulson ME, Hoffman BE, Guastella DB, Dawson VL, Dawson TM (1999) Poly(ADP-ribose) polymerase activation mediates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced parkinsonism. Proc Natl Acad Sci U S A 96:5774-5779.
40. Mayer PR, Huang N, Dewey CM, Dries DR, Zhang H, Yu G (2010) Expression, localization, and biochemical characterization of nicotinamide mononucleotide adenylyltransferase 2. J Biol Chem 285:40387-40396.
41. McCormick DB (1988) Niacin. In: Modern Nutrition in Health and Disease, 6th edition (Shils ME., Young VR, eds), pp370-375.Philadelphia: Lea & Febiger.
42. McCormick DB (1996) Co-enzymes, Biochemistry of. In: Encyclopedia of Molecular Biology and Molecular Medicine (Meyers RA, ed), pp 396-406. Weinheim: VCH.
43. McCormick DB (1997) Co-enzymes, Biochemistry. In: Encyclopedia of Human Biology 2nd edition (Dulbecco R ed.-in-chief). p. 847-864 San Diego: Academic Press.
44. Mukherjee SK, Klaidman LK, Yasharel R, Adams JD (1997) Increased brain NAD prevents neuronal apoptosis in vivo. Eur J Pharmacol 330:27-34.
45. Oliver FJ, Menissier-de Murcia J, De Murcia G (1999) Poly(ADP-Ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease. Am J Hum Genet 64:1282-1288.
46. Pacher P, Szabo C (2007) Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular Diseases: the therapeutic potentia of PARP inhibitors. Cardiovasc Drug Rev 25:235-260.
47. Pieper AA, Verma A, Zhang J, Snyder SH (1999) Poly(ADP)-ribose polymerase, nitric oxide and cell death. Trends Pharmacol Sci 20:171-181.
48. Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GA, Lowry CA. (2006) Tryptophan metabolism in the central nervous system: medical implications. Expert Rev Mol Med 8:1-27.
49. Schapira AH, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, Clark JB, Marsden CD (1990) Anatomic and disease specificity of NADH CoQ 1 reductase (complex I) in Parkinson’s disease. J Neurochem 5:2142-2145.
50. Sorci L, Cimadamore F, Scotti S, Petrelli R, Cappellacci L, Franchetti P, Orsomando G, Magni G (2007) Initial-rate kinetics of human NMN-adenylyltransferases: substrate and metal ion specificity, inhibition by products and multisubstrate analogues, and isozyme contributions to NAD+ biosynthesis. Biochemistry 46:4912-4922.
51. Stone TW (2001) Endogenous neurotoxins from tryptophan. Toxicon 39:61-73.
52. Takahashi K, Pieper AA, Croul SE, Zhang J, Snyder SH, Greenberg JH (1999) Post-treatment with an inhibitor of poly(ADPribose) polymerase attenuates cerebral damage in focal ischemia. Brain Res 829:46-54.
53. Ting K, Brew B, Guillemin G (2009) Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer’s disease. J Neuroinflammation 6:1186-1136.
54. Torvik A (1976) Central chromatolysis and the axon reaction: A reappraisal. Neuropathol Appl Neurobiol 2:423-432.
55. Ungerstedt JS, Blomback M, Soderdtom T (2003) Nicotinamide is a potent inhibitor of proinflammatory cytokines. Clin Exp Immunol 131:48-52.
56. Vincent AM, Stevens MJ, Backus C, Mclean LL, Feldman EL (2005) Cell culture modeling to test therapies against hyperglycemia-mediated oxidative stress and injury. Antioxid Redox Signal 7:1494-1506.
57. Vu CO, Coyle DL, Jacobson EL, Jacobson MK (1997) Intracellular signaling by cylic ADP-Ribose in oxidative cellinjury. FASEB J 11:A1116 (Abstract).
58. Vu CQ, Coyle DL, Tai HH, Jacobson EL, Jacobson MK (1997) “Intramolecular ADP-ribose transfer reactions and calcium signalling,” In ADP-Ribosylation in Animal Tissue: Structure, Function, and Biology of Mono-DPRibosyltransferases and Related Enzymes (F. Haag and F. Koch-Nolte, eds), pp381-388.Plenum Press, New York, NY, USA.
59. Wilson GL, Patton NJ, McCord JM (1984) Mechanisms of streptozotocinand alloxan-induced damage in the rat Bcells. Diabetologia 27:587-591.
60. Yamada K, Nonaka K, Hanafusa T, Miyazaki A, Toyoshima H, Tarui S (1982) Preventative and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis-an observation in nonobese diabetic (NOD) mice. Diabetes 31:749-753.
61. Yan T, Feng Y, Zheng J, Ge X, Zhang Y, Wu D, Zhao J, Zhai Q (2010) Nmnat2 delays axon degeneration in superior cervical ganglia dependent on its NAD synthesis activity. Neurochem Int 56:101-106.
62. Yang J, Klaidman LK, Nalbandian A, Oliver J, Chang ML, Chan PH, Adams JD Jr (2002b) The effects of nicotinamide on energy metabolism following transient focal cerebral ischemia in Wistar rats. Neurosci Lett 333:91-94.
63. Zhai RG, Cao Y, Hiesinger PR, Zhou Y, Mehta SQ, Schulze KL, Verstreken P, Bellen HJ (2006) Drosophila NMNAT maintains neural integrity independent of its NAD synthesis activity. PLoS Biol 4:e416.
64. Zhang J, Pieper A, Snyder SH (1995) Poly(ADP-ribose) synthetase activation: an early indicator of neurotoxic DNA damage. J Neurochem 65:1411-1414.
65. Zhang J, Snyder SH (1992) Nitric oxide stimulates auto-ADPribosylaton of glyceraldehyde-3-phosphate dehydrogenase. Proc Natl Acad Sci U S A 89:9382-9385.
66. Zimmermann HM, Cohen LH, Gildea EF (1934) Pellagra in association with chronic alcoholism. Arch Neurol Psychiat (Chicago) 31:290-309.